Correction
After publication of this work [1], it has come to our attention that there is an error in the author list of the initial version of this manuscript; rather than Ernest J Lam, the second author of the manuscript should be listed as Ernest T Lam.
We publish this correction to update the author list with this information. The correct author list is as follows:
Gunjan D Hariani, Ernest T Lam, Tammy Havener, Pui-Yan Kwok, Howard L McLeod, Michael J Wagner and Alison A Motsinger-Reif
This error was introduced during the final production process and the editors of BMC Research Notes apologise for any inconvenience caused.
References
Hariani GD, Lam EJ, Havener T, Kwok PY, McLeod HL, Wagner MJ, Motsinger-Reif AA: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes. 2014, 7: 360-10.1186/1756-0500-7-360.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1756-0500-7-360
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Hariani, G.D., Lam, E.T., Havener, T. et al. Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes 7, 652 (2014). https://doi.org/10.1186/1756-0500-7-652
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1756-0500-7-652